from The American Heritage® Dictionary of the English Language, 4th Edition
- n. The process by which a drug is absorbed, distributed, metabolized, and eliminated by the body.
- n. The study of this process.
from Wiktionary, Creative Commons Attribution/Share-Alike License
- n. A branch of pharmacology concerned with the rate at which drugs are absorbed, distributed, metabolized, and eliminated by the body.
from WordNet 3.0 Copyright 2006 by Princeton University. All rights reserved.
- n. the study of the action of drugs in the body: method and rate of excretion; duration of effect; etc.
Sorry, no etymologies found.
The study of the kinetics (movement) of chemicals was originally conducted with pharmaceuticals and thus the term pharmacokinetics became commonly used.
Future work must delineate the social and biological factors, including any differences in pharmacokinetics associated with chemotherapeutic agents, that account for disparities in outcome.
In herpes with arrhythmic propranolol treatment of ptsd diluting hemodialysis, label pharmacokinetics were indirectly titrated by excretion and a longer unconscious penicillin of the located mmhg dose is principally tolerated, the binding may predispose discontinued as impaired by one dose/day
This study is evaluating the safety and tolerability of 534 as well as its pharmacokinetics, that is the behavior of the drug in patients, and its pharmacodynamics, the effects of the drug in patient's cells.
- The second part was of a pharmacological nature; it analysed the "pharmacokinetics" of chemotherapy drugs in pregnant women (i.e. the absorption, progression and distribution of the medication in the body) and the "transplacental transfer" of the medication (transfer through the placenta) to the foetus.
Need pharmacokinetics and pharmacodynamics examples …
A one-year open label, non-comparative extension to a randomized, multicenter, phase II study to evaluate the safety, tolerability, pharmacokinetics and the effects on liver iron concentration of repeated doses of 5-30 mg/kg/day of ICL670 (deferasirox) relative to deferoxamine in sickle cell disease patients with transfusional hemosiderosis
Safety and pharmacokinetics of CDP571 in pediatric patients with Crohn's disease
Oral doses are rapidly and completely absorbed, with peak levels reached after 29 to 90 minutes; however, bioavailability is low due to a hepatic first-pass effect. 6 The pharmacokinetics are not significantly affected by gender, age, renal failure or hemodialysis beginning one hour after drug administration.
Evaluation of the efficacy, safety, tolerance, and pharmacokinetics of meropenem for the treatment of acute pulmonary exacerbations in patients with cystic fibrosis.